Wealth Enhancement Advisory Services LLC Raises Position in The Cigna Group (NYSE:CI)

Wealth Enhancement Advisory Services LLC grew its position in shares of The Cigna Group (NYSE:CIFree Report) by 0.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 53,599 shares of the health services provider’s stock after acquiring an additional 372 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in The Cigna Group were worth $14,801,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Marks Group Wealth Management Inc grew its holdings in The Cigna Group by 3,669.7% in the third quarter. Marks Group Wealth Management Inc now owns 24,013 shares of the health services provider’s stock worth $8,319,000 after purchasing an additional 23,376 shares during the period. Principal Financial Group Inc. grew its stake in shares of The Cigna Group by 3.6% in the 3rd quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider’s stock worth $112,216,000 after buying an additional 11,228 shares during the last quarter. Trinity Street Asset Management LLP increased its position in The Cigna Group by 7.1% during the 3rd quarter. Trinity Street Asset Management LLP now owns 81,411 shares of the health services provider’s stock valued at $28,204,000 after buying an additional 5,397 shares in the last quarter. Pine Valley Investments Ltd Liability Co raised its stake in The Cigna Group by 28.3% during the third quarter. Pine Valley Investments Ltd Liability Co now owns 15,713 shares of the health services provider’s stock valued at $5,444,000 after buying an additional 3,466 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. boosted its holdings in The Cigna Group by 6.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 105,479 shares of the health services provider’s stock worth $36,542,000 after acquiring an additional 6,585 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CI shares. Royal Bank of Canada reduced their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Jefferies Financial Group raised their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Barclays upped their price objective on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $395.93.

View Our Latest Analysis on CI

The Cigna Group Trading Down 0.2 %

The Cigna Group stock opened at $278.77 on Friday. The business has a 50-day simple moving average of $304.77 and a two-hundred day simple moving average of $328.45. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The company has a market cap of $77.54 billion, a P/E ratio of 26.30, a P/E/G ratio of 0.88 and a beta of 0.54.

The Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same period in the prior year, the company earned $6.77 earnings per share. The firm’s revenue was up 29.8% on a year-over-year basis. Analysts predict that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th were issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend was Wednesday, December 4th. The Cigna Group’s dividend payout ratio is presently 52.83%.

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.